Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD3 antibody

The Mouse Monoclonal anti-CD3 antibody has been validated for FACS, IHC, WB, ELISA, ICC and in vivo. It is suitable to detect CD3 in samples from Mouse.
Catalog No. ABIN7795302

Quick Overview for Recombinant CD3 antibody (ABIN7795302)

Target

See all CD3 Antibodies
CD3

Antibody Type

Recombinant Antibody

Reactivity

  • 205
  • 106
  • 32
  • 20
  • 17
  • 10
  • 8
  • 8
  • 7
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
Mouse

Host

  • 246
  • 63
  • 20
  • 9
  • 6
  • 4
Mouse

Clonality

  • 334
  • 5
  • 3
  • 1
Monoclonal

Conjugate

  • 112
  • 39
  • 28
  • 24
  • 22
  • 11
  • 8
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD3 antibody is un-conjugated

Application

  • 317
  • 84
  • 59
  • 57
  • 52
  • 36
  • 35
  • 26
  • 17
  • 8
  • 7
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (IHC), Western Blotting (WB), ELISA, Immunocytochemistry (ICC), In vivo Studies (in vivo)

Grade

In vivo Grade

Clone

17A2
  • Expression System

    Mammalian cells

    Purpose

    In vivo Grade Recombinant Anti-mouse CD3 Monoclonal Antibody (Clone: 17A2), Mouse IgG2a Kappa

    Characteristics

    The antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, the antibody, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the antibody, T cells disappear from the circulation within minutes to hours. During treatment with the antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the antibody in vivo. The antibody is ineffective clinically if the CD3 target molecule is not modulated. The antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Endotoxin Level

    < 1 EU per 1 mg of the protein by the LAL method

    Isotype

    IgG2a, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    CD3

    Alternative Name

    CD3

    Pathways

    TCR Signaling, Ubiquitin Proteasome Pathway
You are here:
Chat with us!